Efficacy of Kakamachi( Solanum nigrum Linn) in Metabolic Syndrome

Efficacy of kakamachi(Solanum nigrum Linn) as an add-on medication in Metabolic Syndrome- a randomized placebo controlled trial

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/09/036427

Enrollment

Registered

2021-09-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E789- Disorder of lipoprotein metabolism, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Central obesity: Waist circumference >90 cm (male), 80 cm (female) Hypertriglyceridaemia: >=150 mg/dl or under medication Low HDL cholesterol: Hypertension: 130/85 mm/Hg FPG: >= 100 mg/dL or under medication

Exclusion criteria

Exclusion criteria: Subjects suffering from cardiovascular disease and renal disease Pregnant and lactating mothers HbA1c >=9% BMI >= 35kg/m2

Design outcomes

Primary

Measure	Time frame
Homeostasis model assessment for insulin resistance (HOMA-IR)Timepoint: Baseline 0 th day and 91 st day	—

Secondary

Measure	Time frame
Waist circumference BMI Fasting Plasma Glucose Triglycerides HDL-C Systolic and Diastolic Blood Pressure Timepoint: Waist circumference BMI Fasting Plasma Glucose Triglycerides HDL-C baseline 0 th and 91 st day Systolic and Diastolic Blood Pressure 0 th day 31 st day 61 st day 91 st day	—

Countries

India

Contacts

Public ContactDr Deepa MS

Govt. Ayurveda College , Department of Dravyaguna vijnana

sasikalavarsha@gmail.com8138975285

Outcome results